WCN25-4505 A DESCRIPTIVE STUDY ON THE CLINICOPATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF IgA NEPHROPATHY USING THE INTERNATIONAL IgA NEPHROPATHY PREDICTION TOOL

Immunoglobulin Nephropathy (IgAN) is the most common type of primary glomerulonephritis. Up to 40% of patients with IgAN exhibit variable progression to end-stage kidney disease (ESKD) over 10 to 20 years. Previous studies from India report a biopsy prevalence of 4.5%–16%. IgAN is found to be a severe disease with poor outcomes in most Indian studies. Indian patients tend to have greater proteinuria, a higher incidence of kidney failure, and hypertension at the time of presentation. Although there are well-established clinical and histologic risk factors for kidney function decline, when used individually, they are unable to accurately identify high-risk patients.